phloroglucinol has been researched along with Anxiety in 4 studies
Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.
phloroglucinol : A benzenetriol with hydroxy groups at position 1, 3 and 5.
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to conduct a comprehensive review of kava and SJW, to review any evidence of efficacy, mode of action, pharmacokinetics, safety and use in major depressive disorder, bipolar disorder, seasonal affective disorder (SAD), generalized anxiety disorder, social phobia (SP), panic disorder (PD), obsessive-compulsive disorder (OCD), and post-traumatic stress disorder (PTSD)." | 8.85 | Kava and St. John's Wort: current evidence for use in mood and anxiety disorders. ( Kavanagh, DJ; Sarris, J, 2009) |
| "The objective of this study was to conduct a comprehensive review of kava and SJW, to review any evidence of efficacy, mode of action, pharmacokinetics, safety and use in major depressive disorder, bipolar disorder, seasonal affective disorder (SAD), generalized anxiety disorder, social phobia (SP), panic disorder (PD), obsessive-compulsive disorder (OCD), and post-traumatic stress disorder (PTSD)." | 4.85 | Kava and St. John's Wort: current evidence for use in mood and anxiety disorders. ( Kavanagh, DJ; Sarris, J, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, S | 2 |
| Wang, Y | 1 |
| Xin, Y | 1 |
| Zhang, J | 1 |
| Yang, Z | 1 |
| Liu, C | 1 |
| Zhang, Y | 1 |
| Yu, P | 1 |
| Liu, H | 1 |
| Yao, H | 1 |
| Yao, S | 1 |
| Yuan, SY | 1 |
| Zhang, JC | 1 |
| Sarris, J | 1 |
| Kavanagh, DJ | 1 |
| Zanoli, P | 1 |
| Rivasi, M | 1 |
| Baraldi, C | 1 |
| Baraldi, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Scheme of Primary Prevention of Infection by COVID-19, in Workers: Phase II Controlled Clinical Trial, to be Carried Out in Medellín-Antioquia[NCT04420260] | 152 participants (Actual) | Interventional | 2021-03-18 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for phloroglucinol and Anxiety
| Article | Year |
|---|---|
Kava and St. John's Wort: current evidence for use in mood and anxiety disorders.
Topics: Anthracenes; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Bridged Bicyclo Compounds; Humans; | 2009 |
3 other studies available for phloroglucinol and Anxiety
| Article | Year |
|---|---|
Hyperforin alleviates the psychiatric disorders of adult rats suffered from early maternal separation via activating autophagy.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Autophagy; Beclin-1; Depression; Disks | 2021 |
Hyperforin improves post-stroke social isolation‑induced exaggeration of PSD and PSA via TGF-β.
Topics: Animals; Anxiety; Behavior, Animal; Brain Ischemia; Depression; Hippocampus; Male; Mice, Inbred C57B | 2019 |
Pharmacological activity of hyperforin acetate in rats.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety; Beha | 2002 |